| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a692dd7b907dbbe18691a3101661d68 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 |
| filingDate |
1997-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd35fd86a16ccd965c6449aed0a4c60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27e9b577fcb22908c5770a6755d2c54f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9abe7a8968f0d37ff22808731f55e4a |
| publicationDate |
1998-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9825591-A1 |
| titleOfInvention |
Transdermal drug delivery system for the treatment of heart diseases |
| abstract |
The invention concerns a transdermal drug delivery system (TDDS) for the delivery of nitroglycerin (NG) to humans, which comprises in accordance with the following sequence at least the following three layers: (i) a drug free backing layer; (ii) an optionally cross-linked acrylic adhesive layer having a content of NG and optionally a tackifying agent (tackifyer, tackifying resin or resin); and (iii) an optionally cross-linked acrylic adhesive layer having a content of NG and a tackifying agent; and, in addition, a release liner. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6436433-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9836740-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9836740-A2 |
| priorityDate |
1996-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |